Galina Marsh - Concepedia

Author

Galina Marsh

Biogen (United States)

Also Known As

Galina Marsh

Publications

575

Citations

H-Index

Concepts

All Affiliations

Biogen (United States)Harvard University Newbury College

About

Galina Marsh is an author at Biogen (United States) specializing in medicine, neurodegenerative diseases, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	257
2	Cell Biology	3	3	232
3	Social Sciences	1	1	25
4	Cellular Physiology	1	1	25
5	Immunology	1	1	188

Galina Marsh

Publications

567

Citations

H-Index

Page 1

	Year	Citations
Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models Andreas Weihofen, Yuting Liu, Joseph W. Arndt, Neurobiology of Disease Disease ModelsNeurodegenerative Diseasesα-Syn PathologyAutoimmune DiseaseDisease Phenotypes	2018	188
BIN1 favors the spreading of Tau via extracellular vesicles Andrea Crotti, Hameetha Rajamohamend Sait, Kathleen M. McAvoy, Scientific Reports	2019	161
BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology Mariko Taga, Vladislav Petyuk, Charles C. White, Molecular Neurodegeneration	2020	75
Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice Sam Hana, Michael Peterson, Helen McLaughlin, Gene Therapy	2021	43
Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo Kathleen M. McAvoy, Hameetha Rajamohamed Sait, Galina Marsh, PLoS ONE Cell DeathNon-cell Autonomous EffectsNeurotransmissionCellular NeurobiologyCellular Physiology	2019	25
In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model Yi A. Chen, Mark W. Kankel, Sam Hana, Gene Therapy Vivo GenomeNeurodegenerative DiseasesAmyotrophic Lateral SclerosisSomatic VariantIn Vivo Gene Therapy	2022	25
Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice Tess Torregrosa, Sydney Lehman, Sam Hana, Gene Therapy Gene TherapiesSystems BiologyMolecular NeuroscienceDevelopmental BiologyAav Transduction	2021	19
Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selection Shukkwan K. Chen, Zachary C. E. Hawley, Maria I. Zavodszky, Molecular Therapy — Nucleic Acids	2023	18
RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin Joseph F. Merola, Wenting Wang, Carrie Wager, Lupus Science & Medicine	2021	13

Page 1